SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-065469
Filing Date
2018-12-19
Accepted
2018-12-19 19:00:25
Documents
1
Period of Report
2018-12-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv509353_4.html 4  
1 OWNERSHIP DOCUMENT tv509353_4.xml 4 7150
  Complete submission text file 0001144204-18-065469.txt   8633
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES ST. NEW YORK NY 10013
Business Address
Shapiro David (Reporting) CIK: 0001559570 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 181244406